美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

美国抗疫概念

1,460.36

-9.8593-0.67%

涨家数：8

跌家数：12

平家数：- -

市盈率：- -

高：1,469.90

开：1,469.76

低：1,454.86

收：1,470.19

数据加载中...

总览新闻资讯

高风险下的投资红灯已亮，避开TSLA、MRNA

强生(JNJ.US)自免领域再落重子

智通财经网

核心产品“过气” 真实生物二度赴港IPO

Ocugen, Inc.盘中异动快速上涨5.24%报0.642美元

Ibio, Inc.盘中异动早盘大幅下挫5.15%报4.79美元

Aethlon Medical, Inc.盘中异动早盘股价大跌5.18%报0.531美元

诺瓦瓦克斯医药盘中异动早盘快速拉升5.38%

英国卫生监管机构批准为 60 岁及以上人群接种 Moderna 的 RSV 疫苗

吉利德的中年困境：抱住CAR-T的浮木

OpenAI发布GPT-4.5！史上最贵AI模型，情商逆天引热议，AI巨头混战即将打响

GPT-4.5横空出世！史上最贵AI模型上线，主打情商高，奥特曼竟因"带娃"缺席发布会？

实测GPT4.5：更像人了，有惊喜但提升微妙

Aethlon Medical, Inc.盘中异动临近收盘股价大跌5.03%报0.552美元

Corvus Pharmaceuticals, Inc.盘中异动临近收盘股价大跌5.06%

美国OTC市场Ampio Pharmaceuticals Inc盘中异动急速拉升1352.38%

Equillium, Inc.盘中异动股价大涨5.87%报0.810美元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK4568/news?page=4"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"美国抗疫概念","latestPrice":1460.3265,"timestamp":1741282552643,"preClose":1470.1858,"halted":0,"volume":40633702,"delay":0,"changeRate":-0.006706,"change":-9.859253,"pbRate":4.026038,"amount":2175057763.653579,"amplitude":0.01023,"prevYearClose":1274.8187,"fiveDayClose":1446.7607,"twentyDayClose":1373.9138,"turnoverRate":0.002627,"marketCap":1204879086835,"floatMarketCap":1182654195121,"peRate":31.895692},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1469.9016,"amplitude":0.01023,"preClose":1470.1858,"low":1454.8619,"pbRate":"4.026038","latestPrice":1460.3577,"volume":40637122,"delay":0,"open":1469.7611,"prevYearClose":1274.8187,"prevWeekClose":1463.5875,"prevMonthClose":1463.5875,"prevQuarterClose":1274.8187,"fiveDayClose":1446.7607,"twentyDayClose":1373.9138,"sixtyDayClose":1299.5834,"secType":"PLATE","market":"US","turnoverRate":0.002627,"peRate":31.895692,"marketCap":1204864568531,"floatMarketCap":1182641051297,"timestamp":1741282556709,"nameCN":"美国抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":8,"down":12,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:16,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516578166","title":"高风险下的投资红灯已亮，避开TSLA、MRNA","url":"https://stock-news.laohu8.com/highlight/detail?id=2516578166","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516578166?lang=zh_cn&edition=fundamental","pubTime":"2025-03-03 10:11","pubTimestamp":1740967864,"startTime":"0","endTime":"0","summary":"根据Payne Capital Management高级财富顾问Courtney Garcia的说法，特斯拉和Moderna今年以来的疲软走势不会很快结束。特斯拉的股价自12月创下历史新高以来下跌了42%，受到销售放缓的影响。今年迄今，股价已经下跌了约30%，抹去了与选举相关的兴奋情绪。这位顾问指出，Moderna的主要收入来源是其新冠疫苗，而对该公司mRNA技术管线的投资尚未实现盈利。由于新冠疫苗需求下降，Moderna的疫苗销售下滑，股价今年已下跌了25%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2025/03/03101148478375.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU0823414478.USD","LU1720051017.SGD","LU2750360997.AUD","LU0820561909.HKD","LU2756315664.SGD","BK4598","LU1720051108.HKD","BK4585","LU2213496289.HKD","LU2360107168.USD","LU1674673428.USD","MRNA","LU0316494557.USD","LU0345770993.USD","BK4551","LU0234572021.USD","LU1066051225.USD","BK4527","LU0097036916.USD","IE00BK4W5M84.HKD","BK4533","LU2360106780.USD","BK4568","LU0345769128.USD","BK4588","IE00BSNM7G36.USD","IE00BJLML261.HKD","LU2471134952.CNY","LU2750360641.GBP","TSLA","BK4534","IE00BK4W5L77.USD","LU1551013425.SGD","LU2023250330.USD","LU2290526834.HKD","IE00B1XK9C88.USD","LU1861558580.USD","BK4555","LU1066051498.USD","BK4099","LU0466842654.USD","LU1778281490.HKD","LU1861559042.SGD","LU2087621335.USD","LU2250418816.HKD","LU1629891620.HKD","TSYW.SI","LU1839511570.USD","SG9999015986.USD","LU0820562030.AUD"],"gpt_icon":1},{"id":"2516156246","title":"强生(JNJ.US)自免领域再落重子","url":"https://stock-news.laohu8.com/highlight/detail?id=2516156246","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516156246?lang=zh_cn&edition=fundamental","pubTime":"2025-03-02 07:19","pubTimestamp":1740871184,"startTime":"0","endTime":"0","summary":"旗下古塞奇尤单抗注射液成功获得NMPA批准","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20250302/20250302072252_94998.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20250302/20250302072252_94998.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1256564.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4534","IE00BVYPNV92.GBP","LU2089984988.USD","JNJ","LU1280957306.USD","LU2133065610.SGD","LU2602419157.SGD","LU1066053197.SGD","LU1267930813.SGD","IE00B19Z3581.USD","LU0289739699.SGD","LU1221951046.USD","IE00B1BXHZ80.USD","BK4504","LU1244550577.SGD","LU1935042991.SGD","LU2112291526.USD","LU2129689605.HKD","IE00BJT1NW94.SGD","LU1196500208.SGD","IE00BFTCPJ56.SGD","LU0795875169.SGD","LU0912757837.SGD","BK4568","IE00BGHQF631.EUR","LU0058720904.USD","LU1059921491.USD","LU2347655156.SGD","SG9999002224.SGD","LU0203345920.USD","LU1718418525.SGD","LU0098860793.USD","BK4532","LU1061106388.HKD","LU2129689431.USD","LU0320765646.SGD","LU1894683264.USD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","IE00B19Z3B42.SGD","LU1023059063.AUD","BK4559","IE00BVYPNW00.USD","LU1929549753.HKD","LU0795875086.SGD","BK4550","IE00B42XCP33.USD","LU1430594728.SGD","BK4533"],"gpt_icon":0},{"id":"2516305777","title":"核心产品“过气”  真实生物二度赴港IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2516305777","media":"贝果财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516305777?lang=zh_cn&edition=fundamental","pubTime":"2025-03-01 03:45","pubTimestamp":1740771900,"startTime":"0","endTime":"0","summary":"近期，真实生物再度冲刺港股上市，靠的仍是同一款产品。2023年及2024年，真实生物全部收入均来自阿兹夫定，公司在此期间持续亏损。事实上，真实生物前次IPO亦处在亏损状态。随后，真实生物与53家经销商订立协议。真实生物方面表示，公司预计未来会继续产生大额研发费用。杜锦发曾公开表示，完成B轮融资后，真实生物也将启动港股IPO的进程。真实生物前次IPO募资主要用于阿兹夫定治疗COVID-19的制造和商业化，以及采购阿兹夫定医药原料。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-03-01/doc-inenarnx1885137.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK4139","600196","BNTX","BK0183","BK0012","BK1191","02196","BK0196","BK1515","BK1593","BK4588","BK0175","BK4585","BK4551","BK4568","BK4548","BK0028","BK0187","BK0096","BK0188","BK0060","BK4535"],"gpt_icon":0},{"id":"2516337733","title":"Ocugen, Inc.盘中异动 快速上涨5.24%报0.642美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516337733","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516337733?lang=zh_cn&edition=fundamental","pubTime":"2025-03-01 01:18","pubTimestamp":1740763133,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日01时18分，Ocugen, Inc.股票出现波动，股价大幅拉升5.24%。截至发稿，该股报0.642美元/股，成交量158.93万股，换手率0.55%，振幅6.54%。Ocugen, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。Ocugen, Inc.公司简介：Ocugen Inc公司专注于发现、开发和商业化新型基因和细胞疗法以及疫苗，旨在改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301011853abe111b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301011853abe111b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCGN","BK4563","BK4568","BK4139"],"gpt_icon":0},{"id":"2514731543","title":"Ibio, Inc.盘中异动 早盘大幅下挫5.15%报4.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514731543","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514731543?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 22:56","pubTimestamp":1740754616,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时56分，Ibio, Inc.股票出现波动，股价大幅跳水5.15%。截至发稿，该股报4.79美元/股，成交量27.218万股，换手率2.76%，振幅7.92%。Ibio, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228225656abe0f146&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228225656abe0f146&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBIO","BK4568"],"gpt_icon":0},{"id":"2514785593","title":"Aethlon Medical, Inc.盘中异动 早盘股价大跌5.18%报0.531美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514785593","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514785593?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 22:35","pubTimestamp":1740753352,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时35分，Aethlon Medical, Inc.股票出现波动，股价快速下挫5.18%。截至发稿，该股报0.531美元/股，成交量8451股，换手率0.06%，振幅1.02%。Aethlon Medical, Inc.股票所在的医疗器械行业中，整体涨幅为0.39%。其相关个股中，Monogram Technologies Inc.、Heartsciences Inc.、沃氪医疗涨幅较大，Rapid Micro Biosystems, Inc.、Dih Holding Us, Inc.、沃氪医疗较为活跃，换手率分别为15.08%、4.00%、2.46%，振幅较大的相关个股有Envveno Medical Corporation、Butterfly Network, Inc.、Ainos, Inc.，振幅分别为17.56%、10.19%、8.94%。Aethlon Medical, Inc.公司简介：Aethlon Medical Inc 是一家医疗技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223552abe0ec00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223552abe0ec00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","BK4568","BK4082","AEMD"],"gpt_icon":0},{"id":"2514378509","title":"诺瓦瓦克斯医药盘中异动 早盘快速拉升5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514378509","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514378509?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 22:33","pubTimestamp":1740753180,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时33分，诺瓦瓦克斯医药股票出现波动，股价快速拉升5.38%。截至发稿，该股报7.44美元/股，成交量28.2614万股，换手率0.18%，振幅3.82%。诺瓦瓦克斯医药股票所在的生物技术行业中，整体涨幅为0.05%。诺瓦瓦克斯医药公司简介：诺瓦瓦克斯医药公司是一家开发疫苗的生物技术公司。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗，以应对已知和新出现的疾病威胁。该公司认为，其疫苗技术有可能广泛应用于各种人类传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223300a25801b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223300a25801b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4547","BK4139","BK4568","BK4585","BK4588","NVAX"],"gpt_icon":0},{"id":"2514342384","title":"英国卫生监管机构批准为 60 岁及以上人群接种 Moderna 的 RSV 疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2514342384","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514342384?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 18:48","pubTimestamp":1740739706,"startTime":"0","endTime":"0","summary":"英国卫生监管机构批准为 60 岁及以上人群接种 Moderna 的 RSV 疫苗路透社2月28日 - 英国卫生监管机构周五表示，已批准Moderna公司的MRNA.O疫苗用于保护60岁及以上患者免受由呼吸道合胞病毒(RSV) 引起的下呼吸道疾病的侵袭。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nL3S3PJ0UX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","BK4139","BK4501","BK4534","BK4551","BK4568","BK4548","BK4588","BK4532","BK4585","BK4533"],"gpt_icon":0},{"id":"2514037597","title":"吉利德的中年困境：抱住CAR-T的浮木","url":"https://stock-news.laohu8.com/highlight/detail?id=2514037597","media":"深蓝观","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514037597?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 18:48","pubTimestamp":1740739680,"startTime":"0","endTime":"0","summary":"2017年收购CAR-T巨头公司Kite是吉利德正式进入肿瘤治疗领域的标志。在拓展新领域之前，吉利德优势明显的依然是HIV和CAR-T领域，这也是吉利德布局的重点。在吉利德试水过的多个领域中，CAR-T俨然是目前最拿得出手的招牌。吉利德现在的当务之急是准备补充新一代CAR-T管线。吉利德于2020年3月收购的CD47单抗Magrolimab因安全性问题终止研发，49亿美元的投资打水漂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228231011abe0f449&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228231011abe0f449&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ1G4Q59.USD","GILD","BK4139","BK4230","LU0109394709.USD","IE00B3T34201.USD","IE00B19Z3581.USD","LU0058720904.USD","LU1585245621.USD","LU0234570918.USD","BK4583","BK4568","IE00BSNM7G36.USD","IE0002270589.USD","BK4550","IE00B19Z3B42.SGD","BK4585","LU1571399168.USD","BK4566","LU2087621335.USD","LU1066051498.USD","LU2089984988.USD","LU0320765992.SGD","CAR","BK4578","LU1430594728.SGD","BK4532","LU1839511570.USD","IE00B7SZLL34.SGD","IE00BKVL7J92.USD","LU0289739699.SGD","BK4588","LU0889565916.HKD","LU1066053197.SGD","LU2468319806.SGD","BK4022"],"gpt_icon":0},{"id":"2514680753","title":"OpenAI发布GPT-4.5！史上最贵AI模型，情商逆天引热议，AI巨头混战即将打响","url":"https://stock-news.laohu8.com/highlight/detail?id=2514680753","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514680753?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 08:49","pubTimestamp":1740703799,"startTime":"0","endTime":"0","summary":"2月28日凌晨，OpenAI正式发布了其最新一代基础模型GPT-4.5，这一发布迅速在科技界引起了轩然大波。这款被OpenAI内部代号为“Orion”的模型，不仅被誉为迄今为止规模最大、知识最丰富的聊天模型，更因其高情商和人性化表现而备受瞩目。价格昂贵，引发争议然而，GPT-4.5的高昂价格也成为了人们热议的话题。值得一提的是，OpenAI还计划在未来向免费用户开放GPT-5的使用权限。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/28084948444186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["EQ","BK4139","BK4568"],"gpt_icon":0},{"id":"2514382363","title":"GPT-4.5横空出世！史上最贵AI模型上线，主打情商高，奥特曼竟因\"带娃\"缺席发布会？","url":"https://stock-news.laohu8.com/highlight/detail?id=2514382363","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514382363?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 08:35","pubTimestamp":1740702900,"startTime":"0","endTime":"0","summary":"　　北京时间2月28日凌晨，OpenAI正式发布了GPT-4.5。相较于前代GPT-4，GPT-4.5通过进一步扩展无监督学习技术，增强了模式识别和创造性洞察的能力，为用户带来了更加自然、广泛且精准的交互体验。　　OpenAI CEO山姆·奥特曼在临近发布时表示，同时带来了一个好消息和一个坏消息。奥特曼表示：“好消息是，GPT-4.5是首个让我感觉像是在和一个有深度思考能力的人对话的模型。有好几次，我靠在椅背上，对从人工智能那里得到的真正有用的建议感到惊讶。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tech/2025-02-28/doc-inemyxct2537095.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["EQ","BK4139","BK4568"],"gpt_icon":0},{"id":"2514354332","title":"实测GPT4.5：更像人了，有惊喜但提升微妙","url":"https://stock-news.laohu8.com/highlight/detail?id=2514354332","media":"AI寒武纪","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514354332?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 07:11","pubTimestamp":1740697866,"startTime":"0","endTime":"0","summary":"北京时间凌晨4点钟OpenAI举行一个14分钟左右的直播发布，GPT4.5 终于发布了！知识更渊博，能力更全面除了情商升级， GPT-4.5 的知识储备和能力也得到了显著提升。这次的 GPT-4.5 更是吊足了大家的胃口，毕竟距离 GPT-4 发布已经过去大约两年了！GPT-4: 感觉确实更好，但 Karpathy 也坦言，提升是 微妙的 。GPT-4.5：微妙的提升，依旧令人兴奋带着对 GPT-4 这种“微妙提升”的预期，Karpathy 对 GPT-4.5 进行了测试。这次 GPT-4.5 的预训练算力比 GPT-4 又提升了 10 倍！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8hKW1DoEdqM","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["BK4526","BK4505","BK4552","BK4139","EQ","BK4531","BK4568","BK4108"],"gpt_icon":1},{"id":"2514535393","title":"Aethlon Medical, Inc.盘中异动 临近收盘股价大跌5.03%报0.552美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514535393","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514535393?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 05:00","pubTimestamp":1740690014,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日05时00分，Aethlon Medical, Inc.股票出现异动，股价急速下跌5.03%。截至发稿，该股报0.552美元/股，成交量19.5728万股，换手率1.35%，振幅8.13%。Aethlon Medical, Inc.股票所在的医疗器械行业中，整体跌幅为0.84%。Aethlon Medical, Inc.公司简介：Aethlon Medical Inc 是一家医疗技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280500159632f74e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280500159632f74e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4583","BK4082","AEMD"],"gpt_icon":0},{"id":"2514433086","title":"Corvus Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514433086","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514433086?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 04:57","pubTimestamp":1740689829,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时57分，Corvus Pharmaceuticals, Inc.股票出现异动，股价急速下跌5.06%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1955.27%、424.52%、198.31%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。其他产品包括Ciforadenant 和Mupadolimab 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228045710a256d079&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228045710a256d079&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","CRVS"],"gpt_icon":0},{"id":"2514331790","title":"美国OTC市场Ampio Pharmaceuticals Inc盘中异动 急速拉升1352.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514331790","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514331790?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 03:24","pubTimestamp":1740684241,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日03时24分，美国OTC市场Ampio Pharmaceuticals Inc股票出现波动，股价大幅上涨1352.38%。美国OTC市场Ampio Pharmaceuticals Inc股票所在的生物技术行业中，整体涨幅为0.06%。美国OTC市场Ampio Pharmaceuticals Inc公司简介：Ampio Pharmaceuticals Inc是一家生物制药公司。其候选产品Ampion正在进行临床试验，并被开发用于治疗严重的膝关节骨性关节炎，对COVID-19患者进行静脉治疗，以及对COVID-19引起的呼吸窘迫进行吸入治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228032401abdfaf19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228032401abdfaf19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMPE","BK4535","BK4588","BNTX","BK4007","BK4551","BK4585","BK4548","BK4139","BK4568"],"gpt_icon":0},{"id":"2514132339","title":"Equillium, Inc.盘中异动 股价大涨5.87%报0.810美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514132339","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514132339?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 02:59","pubTimestamp":1740682746,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日02时59分，Equillium, Inc.股票出现波动，股价大幅上涨5.87%。截至发稿，该股报0.810美元/股，成交量2.9874万股，换手率0.08%，振幅6.54%。Equillium, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Quoin Pharmaceuticals Ltd涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1880.38%、320.93%、136.91%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pds Biotechnology Corporation、Pepgen Inc.，振幅分别为86.14%、55.84%、52.94%。Equillium, Inc.公司简介：Equillium Inc 是一家开发治疗自身免疫和炎症疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280259069632e33a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280259069632e33a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","EQ"],"gpt_icon":0}],"pageSize":16,"totalPage":11,"pageCount":4,"totalSize":161}]}}